Literature DB >> 15654051

Sex hormones modulate brain damage in multiple sclerosis: MRI evidence.

V Tomassini1, E Onesti, C Mainero, E Giugni, A Paolillo, M Salvetti, F Nicoletti, C Pozzilli.   

Abstract

BACKGROUND: Sex related differences in the course and severity of multiple sclerosis (MS) could be mediated by the sex hormones.
OBJECTIVE: To investigate the relation between serum sex hormone concentrations and characteristics of tissue damage on conventional magnetic resonance imaging (MRI) in men and women suffering from relapsing-remitting MS.
RESULTS: Serum testosterone was significantly lower in women with MS than in controls. The lowest levels were found in women with a greater number of gadolinium enhancing lesions. A positive correlation was observed between testosterone concentrations and both tissue damage on MRI and clinical disability. In men, there was a positive correlation between oestradiol concentrations and brain damage.
CONCLUSIONS: The hormone related modulation of pathological changes supports the hypothesis that sex hormones play a role in the inflammation, damage, and repair mechanisms typical of MS.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15654051      PMCID: PMC1739476          DOI: 10.1136/jnnp.2003.033324

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  31 in total

1.  Proliferation and death of oligodendrocytes and myelin proteins are differentially regulated in male and female rodents.

Authors:  Mirela Cerghet; Robert P Skoff; Denise Bessert; Zhan Zhang; Chadwick Mullins; M Said Ghandour
Journal:  J Neurosci       Date:  2006-02-01       Impact factor: 6.167

2.  Multimodal analysis in acute and chronic experimental autoimmune encephalomyelitis.

Authors:  Silvia Giatti; Mariaserena Boraso; Federico Abbiati; Elisa Ballarini; Donato Calabrese; Maria Santos-Galindo; Roberta Rigolio; Marzia Pesaresi; Donatella Caruso; Barbara Viviani; Guido Cavaletti; Luis Miguel Garcia-Segura; Roberto Cosimo Melcangi
Journal:  J Neuroimmune Pharmacol       Date:  2012-06-30       Impact factor: 4.147

Review 3.  Multiple sclerosis and sexual dysfunction.

Authors:  Zhen-Ni Guo; Si-Yuan He; Hong-Liang Zhang; Jiang Wu; Yi Yang
Journal:  Asian J Androl       Date:  2012-03-26       Impact factor: 3.285

4.  Castration attenuates myelin repair following lysolecithin induced demyelination in rat optic chiasm: an evaluation using visual evoked potential, marker genes expression and myelin staining.

Authors:  Mohammad Amin Sherafat; Mohammad Javan; Sabah Mozafari; Javad Mirnajafi-Zadeh; Fereshteh Motamedi
Journal:  Neurochem Res       Date:  2011-05-28       Impact factor: 3.996

5.  Low testosterone is associated with disability in men with multiple sclerosis.

Authors:  R Bove; A Musallam; B C Healy; K Raghavan; B I Glanz; R Bakshi; H Weiner; P L De Jager; K K Miller; T Chitnis
Journal:  Mult Scler       Date:  2014-04-07       Impact factor: 6.312

6.  Estradiol inhibits ongoing autoimmune neuroinflammation and NFkappaB-dependent CCL2 expression in reactive astrocytes.

Authors:  Sébastien N Giraud; Cécile M Caron; Danielle Pham-Dinh; Patrick Kitabgi; Arnaud B Nicot
Journal:  Proc Natl Acad Sci U S A       Date:  2010-04-19       Impact factor: 11.205

Review 7.  Autoimmune diseases and reproductive aging.

Authors:  Riley Bove
Journal:  Clin Immunol       Date:  2013-02-28       Impact factor: 3.969

Review 8.  Sexual dimorphism in the white matter of rodents.

Authors:  Mirela Cerghet; Robert P Skoff; Muthulekha Swamydas; Denise Bessert
Journal:  J Neurol Sci       Date:  2009-07-22       Impact factor: 3.181

9.  Sexual dimorphism of oligodendrocytes is mediated by differential regulation of signaling pathways.

Authors:  Muthulekha Swamydas; Denise Bessert; Robert Skoff
Journal:  J Neurosci Res       Date:  2009-11-15       Impact factor: 4.164

10.  Multiple sclerosis patients show sexual dimorphism in cytokine responses to myelin antigens.

Authors:  Ioana R Moldovan; Anne C Cotleur; Natacha Zamor; Robert S Butler; Clara M Pelfrey
Journal:  J Neuroimmunol       Date:  2007-11-26       Impact factor: 3.478

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.